tiprankstipranks
Trending News
More News >
Bavarian Nordic AS (DE:BV3)
XETRA:BV3

Compare Bavarian Nordic AS (BV3) vs. Competitors

Compare
24 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Bavarian Nordic AS
€26.58
kr2.13B
6.35
5.48%
Bavarian Nordic AS
kr198.75
kr15.90B
6.36
3.64%
Hikma Pharmaceuticals
1567.00p
£3.45B
12.09
-22.98%
5 Buy
0 Hold
1 Sell
Moderate Buy
AstraZeneca
14026.00p
£222.43B
30.89
31.72%
12 Buy
2 Hold
1 Sell
Moderate Buy
GlaxoSmithKline
1848.00p
£75.86B
13.90
39.21%
3 Buy
8 Hold
4 Sell
Hold
PureTech Health
134.80p
£326.27M
9.45
-6.64%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:BV3
Bavarian Nordic AS
26.58
0.70
2.70%
GB:0DPB
Bavarian Nordic AS
198.75
3.74
1.92%
GB:HIK
Hikma Pharmaceuticals
1,562.00
-443.30
-22.11%
GB:AZN
AstraZeneca
14,026.00
3,411.82
32.14%
GB:GSK
GlaxoSmithKline
1,848.00
556.32
43.07%
GB:INDV
GB:PRTC
PureTech Health
135.00
-9.60
-6.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts